Mannatech (MTEX)
Mannatech on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as medicinal chemicals & botanical products.
12K
Short interest
settlement 2026-10-15
1.0
Days to cover
unchanged vs prior
11.0%
Short share of volume
2026-11-02
490
Fails to deliver
settlement 2026-08-17
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in MTEX is 11,556 shares, down 1,284 shares over the last month. Over the last 48 readings it ranged from 2,164 shares (31 October 2024) to 41,501 shares (15 May 2026). At the reported average volume of 24K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/mtex" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 11,556 | -10.1% | 23,992 | 1.00 |
| 2026-09-30 | 12,860 | +0.2% | 20,645 | 1.00 |
| 2026-09-15 | 12,840 | -42.1% | 92,879 | 1.00 |
| 2026-08-31 | 22,195 | -2.3% | 7,899 | 2.81 |
| 2026-08-14 | 22,719 | +45.0% | 12,614 | 1.80 |
| 2026-07-31 | 15,669 | +0.7% | 10,802 | 1.45 |
| 2026-07-15 | 15,557 | +37.0% | 5,883 | 2.64 |
| 2026-06-30 | 11,358 | -60.3% | 25,175 | 1.00 |
| 2026-06-15 | 28,596 | -21.0% | 7,823 | 3.66 |
| 2026-05-29 | 36,191 | -12.8% | 44,883 | 1.00 |
| 2026-05-15 | 41,501 | +62.2% | 86,348 | 1.00 |
| 2026-04-30 | 25,588 | -2.6% | 4,517 | 5.66 |
| 2026-04-15 | 26,281 | +120.6% | 33,875 | 1.00 |
| 2026-03-31 | 11,912 | +4.0% | 3,393 | 3.51 |
| 2026-03-13 | 11,458 | -9.1% | 3,190 | 3.59 |
| 2026-02-27 | 12,610 | -18.1% | 2,059 | 6.12 |
| 2026-02-13 | 15,393 | -17.7% | 5,960 | 2.58 |
| 2026-01-30 | 18,710 | +4.3% | 14,011 | 1.34 |
| 2026-01-15 | 17,947 | -27.2% | 48,014 | 1.00 |
| 2025-12-31 | 24,659 | +112.2% | 31,236 | 1.00 |
| 2025-12-15 | 11,621 | -22.7% | 2,968 | 3.92 |
| 2025-11-28 | 15,030 | -26.4% | 5,077 | 2.96 |
| 2025-11-14 | 20,412 | +8.6% | 34,907 | 1.00 |
| 2025-10-31 | 18,789 | -50.9% | 19,278 | 1.00 |
| 2025-10-15 | 38,269 | +306.2% | 75,312 | 1.00 |
| 2025-09-30 | 9,422 | +28.7% | 32,263 | 1.00 |
| 2025-09-15 | 7,319 | -23.2% | 14,851 | 1.00 |
| 2025-08-29 | 9,531 | -29.1% | 8,420 | 1.13 |
| 2025-08-15 | 13,451 | +53.5% | 16,256 | 1.00 |
| 2025-07-31 | 8,762 | +101.4% | 21,742 | 1.00 |
| 2025-07-15 | 4,351 | -20.6% | 9,884 | 1.00 |
| 2025-06-30 | 5,481 | -12.5% | 23,131 | 1.00 |
| 2025-06-13 | 6,263 | +19.6% | 3,880 | 1.61 |
| 2025-05-30 | 5,236 | -26.5% | 3,951 | 1.33 |
| 2025-05-15 | 7,122 | -2.7% | 653 | 10.91 |
| 2025-04-30 | 7,322 | -18.0% | 1,347 | 5.44 |
| 2025-04-15 | 8,927 | -25.4% | 2,337 | 3.82 |
| 2025-03-31 | 11,962 | -14.3% | 2,756 | 4.34 |
| 2025-03-14 | 13,965 | +1.7% | 6,617 | 2.11 |
| 2025-02-28 | 13,732 | -10.3% | 4,805 | 2.86 |
| 2025-02-14 | 15,305 | +20.5% | 2,970 | 5.15 |
| 2025-01-31 | 12,703 | -17.9% | 7,917 | 1.60 |
| 2025-01-15 | 15,475 | +48.4% | 4,713 | 3.28 |
| 2024-12-31 | 10,428 | +121.5% | 8,169 | 1.28 |
| 2024-12-13 | 4,709 | +10.4% | 9,124 | 1.00 |
| 2024-11-29 | 4,265 | +61.7% | 4,693 | 1.00 |
| 2024-11-15 | 2,637 | +21.9% | 3,116 | 1.00 |
| 2024-10-31 | 2,164 | -10.0% | 2,941 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of MTEX volume is 11.0%, down 37.6 points over the last five sessions. Over the last 30 readings it ranged from 10.3% (6 October 2026) to 85.7% (22 October 2026). The latest reading sits at the bottom of that range. The latest reading is 35.7 points below the 30-session average of 46.7%, on 898 shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 99 | 898 | 11.0% | 0 |
| 2026-10-30 | 236 | 342 | 69.0% | 0 |
| 2026-10-29 | 1K | 2K | 70.6% | 0 |
| 2026-10-28 | 1K | 2K | 63.6% | 0 |
| 2026-10-27 | 2K | 3K | 56.3% | 0 |
| 2026-10-26 | 1K | 2K | 48.6% | 0 |
| 2026-10-23 | 379 | 832 | 45.6% | 0 |
| 2026-10-22 | 1K | 2K | 85.7% | 0 |
| 2026-10-21 | 2K | 3K | 60.9% | 0 |
| 2026-10-20 | 4K | 7K | 52.2% | 0 |
| 2026-10-19 | 1K | 3K | 38.2% | 0 |
| 2026-10-16 | 1K | 5K | 25.4% | 0 |
| 2026-10-15 | 2K | 7K | 26.6% | 0 |
| 2026-10-14 | 650 | 1K | 49.2% | 0 |
| 2026-10-13 | 490 | 926 | 52.9% | 0 |
| 2026-10-12 | 3K | 4K | 77.9% | 0 |
| 2026-10-09 | 562 | 1K | 51.5% | 0 |
| 2026-10-08 | 320 | 648 | 49.4% | 0 |
| 2026-10-07 | 403 | 718 | 56.1% | 0 |
| 2026-10-06 | 1K | 12K | 10.3% | 0 |
| 2026-10-05 | 346 | 3K | 11.8% | 0 |
| 2026-10-02 | 640 | 3K | 24.6% | 0 |
| 2026-10-01 | 653 | 1K | 54.0% | 0 |
| 2026-09-30 | 1K | 2K | 69.3% | 0 |
| 2026-09-29 | 710 | 1K | 51.2% | 0 |
| 2026-09-28 | 637 | 2K | 32.4% | 0 |
| 2026-09-25 | 3K | 6K | 42.2% | 54 |
| 2026-09-24 | 331 | 933 | 35.5% | 38 |
| 2026-09-23 | 434 | 3K | 14.0% | 0 |
| 2026-09-22 | 653 | 990 | 66.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 17 August 2026, the fails-to-deliver balance in MTEX is 490 shares, down 101 shares over the last settlement date. Over the last 30 readings it ranged from 6 shares (8 April 2026) to 10,755 shares (11 May 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-17 | 490 | $6.25 | $3K |
| 2026-08-14 | 591 | $6.15 | $4K |
| 2026-08-11 | 40 | $5.00 | $200 |
| 2026-07-24 | 1,297 | $5.05 | $7K |
| 2026-06-17 | 3,000 | $5.43 | $16K |
| 2026-05-28 | 614 | $5.38 | $3K |
| 2026-05-27 | 3,098 | $5.53 | $17K |
| 2026-05-12 | 9,748 | $5.11 | $50K |
| 2026-05-11 | 10,755 | $5.60 | $60K |
| 2026-05-07 | 435 | $4.68 | $2K |
| 2026-04-15 | 54 | $4.84 | $261 |
| 2026-04-08 | 6 | $6.24 | $37 |
| 2026-03-25 | 83 | $6.99 | $580 |
| 2026-03-24 | 128 | $6.86 | $878 |
| 2026-03-19 | 47 | $6.57 | $309 |
| 2026-03-18 | 96 | $6.26 | $601 |
| 2026-03-16 | 16 | $6.46 | $103 |
| 2026-03-13 | 52 | $6.20 | $322 |
| 2026-02-18 | 2,356 | $7.16 | $17K |
| 2026-02-13 | 133 | $7.33 | $975 |
| 2026-02-11 | 342 | $7.39 | $3K |
| 2026-02-04 | 1,109 | $7.58 | $8K |
| 2026-01-26 | 260 | $7.69 | $2K |
| 2026-01-23 | 105 | $7.56 | $794 |
| 2026-01-22 | 502 | $7.40 | $4K |
| 2026-01-20 | 918 | $7.61 | $7K |
| 2026-01-16 | 3,604 | $9.00 | $32K |
| 2026-01-08 | 209 | $8.00 | $2K |
| 2026-01-06 | 236 | $7.87 | $2K |
| 2025-12-31 | 1,187 | $7.95 | $9K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for MTEX in the last 90 days. The most recent filings are listed below. Latest filing: JOBE LARRY A (Director) on 2026-05-20.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | JOBE LARRY A | Director | Buy | 3K | $4.12 | $12K | 70K |
| 2026-05-19 | Robbins Kevin Andrew | Director | Buy | 7K | $4.17 | $30K | 33K |
| 2026-05-19 | JOBE LARRY A | Director | Buy | 5K | $4.20 | $21K | 67K |
| 2026-01-02 | Robbins Kevin Andrew | Director | Grant | 5K | $8.35 | $40K | 26K |
| 2026-01-02 | TOTH ROBERT | Director | Grant | 5K | $8.35 | $40K | 96K |
| 2026-01-02 | Rameson Tyler | Director | Grant | 5K | $8.35 | $40K | 307K |
| 2026-01-02 | John Seifrick A | Director | Grant | 5K | $8.35 | $40K | 14K |
| 2026-01-02 | JOBE LARRY A | Director | Grant | 5K | $8.35 | $40K | 62K |
| 2026-01-02 | FREDRICK J STANLEY | Director | Grant | 5K | $8.35 | $40K | 362K |
| 2025-01-02 | John Seifrick A | Director | Grant | 3K | $14.89 | $40K | 9K |
| 2025-01-02 | Rameson Tyler | Director | Grant | 3K | $14.89 | $40K | 302K |
| 2025-01-02 | Robbins Kevin Andrew | Director | Grant | 3K | $14.89 | $40K | 21K |
| 2025-01-02 | JOBE LARRY A | Director | Grant | 3K | $14.89 | $40K | 57K |
| 2025-01-02 | TOTH ROBERT | Director | Grant | 3K | $14.89 | $40K | 91K |
| 2025-01-02 | FREDRICK J STANLEY | Director | Grant | 3K | $14.89 | $40K | 357K |
| 2024-09-09 | Rameson Tyler | Director | Buy | 16K | $7.75 | $126K | 299K |
| 2024-09-09 | JOBE LARRY A | Director | Sell | 16K | $7.75 | $126K | 55K |
| 2024-05-22 | JOBE LARRY A | Director | Sell | 1K | $7.60 | $8K | 71K |
| 2024-03-11 | Fredrick Landen Granvel | COO/Interim CFO | Grant | 8K | $9.16 | $75K | 12K |
| 2024-01-02 | FREDRICK J STANLEY | Director | Grant | 5K | $8.11 | $40K | 354K |
| 2024-01-02 | JOBE LARRY A | Director | Grant | 5K | $8.11 | $40K | 72K |
| 2024-01-02 | Rameson Tyler | Director | Grant | 5K | $8.11 | $40K | 283K |
| 2024-01-02 | Robbins Kevin Andrew | Director | Grant | 5K | $8.11 | $40K | 19K |
| 2024-01-02 | John Seifrick A | Director | Grant | 5K | $8.11 | $40K | 6K |
| 2024-01-02 | FREDRICK J STANLEY | Director | Grant | 5K | $8.11 | $40K | 229K |
| 2023-08-30 | BALA ALFREDO | CEO and President | Sell | 1K | $12.40 | $12K | 3K |
| 2023-08-18 | JOBE LARRY A | Director | Sell | 1K | $12.82 | $16K | 67K |
| 2023-06-30 | BALA ALFREDO | CEO and President | Sell | 115 | $12.62 | $1K | 4K |
| 2023-06-29 | BALA ALFREDO | CEO and President | Sell | 154 | $12.89 | $2K | 4K |
| 2023-02-14 | Fredrick Landen Granvel | Chief Sales/Marketing Officer | Exercise or conversion | 2K | $5.72 | $11K | 4K |
| 2023-01-03 | John Seifrick A | Director | Grant | 1K | $17.43 | $23K | 1K |
| 2023-01-03 | Rameson Tyler | Director | Grant | 2K | $17.43 | $40K | 278K |
| 2023-01-03 | TOTH ROBERT | Director | Grant | 2K | $17.43 | $40K | 88K |
| 2023-01-03 | FREDRICK J STANLEY | Director | Grant | 2K | $17.43 | $40K | 224K |
| 2023-01-03 | JOBE LARRY A | Director | Grant | 2K | $17.43 | $40K | 68K |
| 2023-01-03 | Robbins Kevin Andrew | Director | Grant | 2K | $17.43 | $40K | 14K |
| 2022-12-21 | BALA ALFREDO | CEO and President | Sell | 4K | $19.69 | $69K | 4K |
| 2022-12-08 | Robbins Kevin Andrew | Director | Sell | 2K | $22.00 | $33K | 12K |
| 2022-03-28 | Robbins Kevin Andrew | Director | Sell | 1K | $36.57 | $40K | 13K |
| 2022-01-03 | JOBE LARRY A | Director | Grant | 1K | $39.49 | $40K | 66K |
| 2022-01-03 | Robbins Kevin Andrew | Director | Grant | 1K | $39.49 | $40K | 14K |
| 2022-01-03 | Rameson Tyler | Director | Grant | 1K | $39.49 | $40K | 276K |
| 2022-01-03 | FREDRICK J STANLEY | Director | Grant | 1K | $39.49 | $40K | 222K |
| 2022-01-03 | SCHRIER ERIC W | Director | Grant | 1K | $39.49 | $40K | 19K |
| 2022-01-03 | TOTH ROBERT | Director | Grant | 1K | $39.49 | $40K | 86K |
| 2021-11-30 | Unknown | CEO and President | Tax withholding | 3K | $35.97 | $98K | 8K |
| 2021-11-30 | Unknown | CEO and President | Exercise or conversion | 5K | $19.60 | $98K | 11K |
| 2021-11-29 | Barta Erin Kemmler | General Counsel | Exercise or conversion | 3K | $5.72 | $17K | 3K |
| 2021-11-29 | BALA ALFREDO | CEO and President | Exercise or conversion | 1K | $15.70 | $18K | 6K |
| 2021-11-23 | Johnson David Allen | Chief Financial Officer | Exercise or conversion | 13K | $15.70 | $196K | 13K |
| 2021-09-07 | Norman Ronald Dale | Sr VP Treasury | Exercise or conversion | 5K | $5.72 | $29K | 6K |
| 2021-09-01 | TOTH ROBERT | Director | Exercise or conversion | 3K | $16.93 | $56K | 85K |
| 2021-09-01 | TOTH ROBERT | Director | Exercise or conversion | 5K | $19.60 | $98K | 82K |
| 2021-08-30 | SCHRIER ERIC W | Director | Exercise or conversion | 5K | $21.18 | $106K | 23K |
| 2021-08-30 | SCHRIER ERIC W | Director | Tax withholding | 5K | $33.89 | $177K | 18K |
| 2021-08-30 | SCHRIER ERIC W | Director | Exercise or conversion | 5K | $14.19 | $71K | 18K |
| 2021-08-26 | Robbins Kevin Andrew | Director | Exercise or conversion | 5K | $17.28 | $86K | 13K |
| 2021-08-24 | FREDRICK J STANLEY | Director | Exercise or conversion | 5K | $5.72 | $29K | 221K |
| 2021-08-23 | Robbins Kevin Andrew | Director | Sell | 2K | $32.99 | $49K | 8K |
| 2021-08-20 | Robbins Kevin Andrew | Director | Sell | 1K | $32.24 | $32K | 10K |
| 2021-08-19 | Robbins Kevin Andrew | Director | Sell | 500 | $31.99 | $16K | 11K |
| 2021-08-17 | Robbins Kevin Andrew | Director | Sell | 2K | $30.83 | $62K | 11K |
| 2021-08-17 | Robbins Kevin Andrew | Director | Sell | 11 | $31.99 | $352 | 11K |
| 2021-03-23 | JOBE LARRY A | Director | Buy | 898 | $17.50 | $16K | 65K |
| 2021-01-04 | FREDRICK J STANLEY | Director | Grant | 2K | $18.68 | $35K | 216K |
| 2021-01-04 | JOBE LARRY A | Director | Grant | 2K | $18.68 | $35K | 64K |
| 2021-01-04 | Rameson Tyler | Director | Grant | 2K | $18.68 | $35K | 275K |
| 2021-01-04 | Robbins Kevin Andrew | Director | Grant | 2K | $18.68 | $35K | 13K |
| 2021-01-04 | SCHRIER ERIC W | Director | Grant | 2K | $18.68 | $35K | 13K |
| 2021-01-04 | TOTH ROBERT | Director | Grant | 2K | $18.68 | $35K | 82K |
| 2020-12-07 | TOTH ROBERT | Director | Exercise or conversion | 5K | $14.18 | $71K | 87K |
| 2020-12-07 | TOTH ROBERT | Director | Exercise or conversion | 5K | $14.68 | $73K | 82K |
| 2020-12-07 | TOTH ROBERT | Director | Tax withholding | 7K | $19.85 | $144K | 80K |
| 2020-09-25 | Robbins Kevin Andrew | Director | Sell | 1K | $16.75 | $17K | 11K |
| 2020-09-24 | BALA ALFREDO | CEO and President | Sell | 4K | $16.48 | $58K | 4K |
| 2020-09-24 | FREDRICK J STANLEY | Director | Buy | 4K | $16.48 | $58K | 214K |
| 2020-06-29 | TOTH ROBERT | Director | Exercise or conversion | 13K | $11.40 | $150K | 89K |
| 2020-06-29 | TOTH ROBERT | Director | Tax withholding | 12K | $15.00 | $179K | 77K |
| 2020-06-29 | TOTH ROBERT | Director | Exercise or conversion | 5K | $5.72 | $29K | 76K |
| 2020-06-23 | TOTH ROBERT | Director | Grant | 5K | $16.93 | $85K | 71K |
| 2020-01-02 | FREDRICK J STANLEY | Director | Grant | 2K | $15.90 | $35K | 211K |
| 2020-01-02 | JOBE LARRY A | Director | Grant | 2K | $15.90 | $35K | 62K |
| 2020-01-02 | Rameson Tyler | Director | Grant | 2K | $15.90 | $35K | 273K |
| 2020-01-02 | Robbins Kevin Andrew | Director | Grant | 2K | $15.90 | $35K | 12K |
| 2020-01-02 | SCHRIER ERIC W | Director | Grant | 2K | $15.90 | $35K | 11K |
| 2020-01-02 | TOTH ROBERT | Director | Grant | 2K | $15.90 | $35K | 66K |
| 2020-01-02 | FREDRICK J STANLEY | Director | Grant | 2K | $15.70 | $35K | 211K |
| 2020-01-02 | JOBE LARRY A | Director | Grant | 2K | $15.70 | $35K | 62K |
| 2020-01-02 | Rameson Tyler | Director | Grant | 2K | $15.70 | $35K | 273K |
| 2020-01-02 | Robbins Kevin Andrew | Director | Grant | 2K | $15.70 | $35K | 12K |
| 2020-01-02 | SCHRIER ERIC W | Director | Grant | 2K | $15.70 | $35K | 11K |
| 2020-01-02 | TOTH ROBERT | Director | Grant | 2K | $15.70 | $35K | 66K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of MTEX in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is LACORE TERRY at 8.3% of the class (159,585 shares), filed 2026-08-19 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-19 | 13G/Ano. 2 | LACORE TERRYindividual | 160K | 8.3% | 2026-06-30 |
| 2026-04-24 | 13D | TOTH ROBERTindividual | 99K | 5.1% | 2026-01-02 |
13F holders
Tracked managers holding MTEX at their latest 13F. JSON1 of the 30 tracked managers held MTEX at their latest 13F, $157K in total at quarter-end prices. Renaissance Technologies is the largest at $157K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 30K | $157K | 0.00% | -800 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Mannatech in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Mannatech (MTEX), SEC CIK 1056358, listed on Nasdaq, classified by the SEC as medicinal chemicals & botanical products. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-08-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-19.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-05-20.JSON and CSV
- Company record
- EDGAR filing index for CIK 1056358Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as medicinal chemicals & botanical products
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of MTEX is sold short?
What is MTEX's daily short volume?
Does MTEX have fails to deliver?
Are MTEX insiders buying or selling?
Who owns 5% or more of MTEX?
Which tracked 13F managers own MTEX?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.